Global stocks gained ground on Monday, as President Donald Trump signaled he would take an aggressive approach in pushing medical treatments to fight coronavirus. After Trump accused the Food and Drug Administration of trying to sabotage his re-election efforts, the FDA gave emergency approval for the use of blood plasma from recovered coronavirus patients, which hasn’t been proved by scientific trials. The Financial Times said Trump may order the FDA to grant approval to the University of Oxford vaccine to be distributed by AstraZeneca by the same manner. AstraZeneca shares rose 2%. “Markets have naturally been very sensitive to vaccine developments in recent months and it seems we’re getting a bit of a bump this morning once again,” said Craig Erlam, senior market analyst at Oanda Europe. Markets seemingly ignored Trump’s comment to Fox News that “we don’t have to” do business with China. While there is no major economic report due for release on Monday, attention is building to the annual Jackson Hole conference, where Federal Reserve Chairman Jerome Powell is expected to outline the central bank’s new inflation strategy. Bank of England Governor Andrew Bailey also will address that conference. “We maintain our view that Federal Reserve support will be a more important driver for risk assets than Covid-19 or other factors, such as U.S.-China tensions and the U.S. election. We also think that this story has not been fully priced into markets,” said Mark Haefele, chief investment officer at UBS Global Wealth Management.